Cargando…

A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India

INTRODUCTION: Deficiency of factor VIII (Hemophilia A), factor IX (Hemophilia B) and Von Willebrand's factor are the most frequent coagulation defects. The incidence of inhibitors in patients of factor VIII deficiency is varies in different regions of India. AIM: To determine the prevalence, cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sandip, Sinha, Sachidanand, Bharti, Anju, Meena, Lalit P., Gupta, Vineeta, Shukla, Jyoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691464/
https://www.ncbi.nlm.nih.gov/pubmed/31463277
http://dx.doi.org/10.4103/jfmpc.jfmpc_316_19
_version_ 1783443388881698816
author Kumar, Sandip
Sinha, Sachidanand
Bharti, Anju
Meena, Lalit P.
Gupta, Vineeta
Shukla, Jyoti
author_facet Kumar, Sandip
Sinha, Sachidanand
Bharti, Anju
Meena, Lalit P.
Gupta, Vineeta
Shukla, Jyoti
author_sort Kumar, Sandip
collection PubMed
description INTRODUCTION: Deficiency of factor VIII (Hemophilia A), factor IX (Hemophilia B) and Von Willebrand's factor are the most frequent coagulation defects. The incidence of inhibitors in patients of factor VIII deficiency is varies in different regions of India. AIM: To determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of Hemophilia in north eastern part of India. METHODS: Selected patients were under went for complete Blood Count (CBC), General Blood Picture (GBP), Prothrombin time (PT), Activated partial thromboplastin time (APTT), Thrombin time, Correction experiment to know the specific factor deficiency or inhibitors present by Normal Plasma, Normal aged serum, Al(OH)(3) adsorbed plasma. RESULTS: 92 patients diagnosed as suffering with Hemophilia A or B were included in study. The age of patients ranged from 2.5 month to 53 years. Out of 92, seventy nine (85.87%) were Haemophilia A and thirteen were (14.13%) Hemophilia B patients. 3.50% (2/55) cases of treated Hemophilia A patient develop inhibitor. CONCLUSION: The prevalence of hemophilia and incidence of inhibitors in these patients is varies in different regions of India. This variation may be due to the type of product used as treatment, intensity of treatment or the genetic characteristics of the patients.
format Online
Article
Text
id pubmed-6691464
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66914642019-08-28 A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India Kumar, Sandip Sinha, Sachidanand Bharti, Anju Meena, Lalit P. Gupta, Vineeta Shukla, Jyoti J Family Med Prim Care Original Article INTRODUCTION: Deficiency of factor VIII (Hemophilia A), factor IX (Hemophilia B) and Von Willebrand's factor are the most frequent coagulation defects. The incidence of inhibitors in patients of factor VIII deficiency is varies in different regions of India. AIM: To determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of Hemophilia in north eastern part of India. METHODS: Selected patients were under went for complete Blood Count (CBC), General Blood Picture (GBP), Prothrombin time (PT), Activated partial thromboplastin time (APTT), Thrombin time, Correction experiment to know the specific factor deficiency or inhibitors present by Normal Plasma, Normal aged serum, Al(OH)(3) adsorbed plasma. RESULTS: 92 patients diagnosed as suffering with Hemophilia A or B were included in study. The age of patients ranged from 2.5 month to 53 years. Out of 92, seventy nine (85.87%) were Haemophilia A and thirteen were (14.13%) Hemophilia B patients. 3.50% (2/55) cases of treated Hemophilia A patient develop inhibitor. CONCLUSION: The prevalence of hemophilia and incidence of inhibitors in these patients is varies in different regions of India. This variation may be due to the type of product used as treatment, intensity of treatment or the genetic characteristics of the patients. Wolters Kluwer - Medknow 2019-07 /pmc/articles/PMC6691464/ /pubmed/31463277 http://dx.doi.org/10.4103/jfmpc.jfmpc_316_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kumar, Sandip
Sinha, Sachidanand
Bharti, Anju
Meena, Lalit P.
Gupta, Vineeta
Shukla, Jyoti
A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
title A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
title_full A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
title_fullStr A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
title_full_unstemmed A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
title_short A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
title_sort study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in north eastern part of india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691464/
https://www.ncbi.nlm.nih.gov/pubmed/31463277
http://dx.doi.org/10.4103/jfmpc.jfmpc_316_19
work_keys_str_mv AT kumarsandip astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT sinhasachidanand astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT bhartianju astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT meenalalitp astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT guptavineeta astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT shuklajyoti astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT kumarsandip studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT sinhasachidanand studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT bhartianju studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT meenalalitp studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT guptavineeta studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia
AT shuklajyoti studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia